Beta-blockers effects according to sex: does selectivity and dose equally matter?

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Elisabetta Salvioni

Monzino Cardiology Centre, Milan (Italy)

7 More presentations in this session

Presentation thumbnail

Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure

Doctor Y. Nishihara (Kobe, JP)

Abstract Slides Video

Presentation thumbnail

Real world data on adopting guideline directed medical therapy post 2021 ESC HF guidelines and effect on renal function.

Mr M. Ferrari (Brescia, IT)

Abstract Slides Video

Presentation thumbnail

Use of guideline-recommended heart failure drugs in high-, middle- and low-income countries: a systematic review and meta-analysis

Associate Professor S. Peters (Utrecht, NL)

Abstract Slides Video

Presentation thumbnail

Candidacy and predicted efficacy of vericiguat in contemporary heart failure outpatient clinics

Doctor B. Soh (Galway, IE)

Abstract Slides Video

Presentation thumbnail

Quadruple therapy for heart failure before and after electronic cardiac device implantation - are we hitting our targets?

Doctor F. Rode (Zagreb, HR)

Abstract Slides Video

Access the full session

Session thumbnail

Pharmacotherapy in heart failure

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

You may be interested in

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources